Social determinants of health (SDOH) strongly influence the development and progression of diabetes (1). As SDOH are infrequently measured in diabetes clinical trials, little is known about how these measures, on both county and individual levels, influence the findings of clinical trials. We sought to compare SDOH in U.S. counties used versus not used for clinical trial sites in guideline-changing studies evaluating pharmacologic treatment for glycemic control.
Patiëntvoorbeelden m.b.t. vergoeding
- ten laste van verzekeraar
- geen vergoeding door verzekeraar